Estimates Revisions Alterity Therapeutics Limited Nasdaq
Stocks
ATHE
US02155X2053
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.980 USD | -2.06% |
|
-8.29% | +61.69% |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
| - | ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Cash or Net Debt
- Stock Market
- Stocks
- ATH Stock
- ATHE Stock
- Consensus Alterity Therapeutics Limited
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
















